Carrie Yuen is an Oncology physician affiliated with Houston Methodist. OpenAlex indexes 49 publications with 962 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6445 Main St
Houston, TX 770301502
Telephone
713-441-9948Provider last certified this registry record 1 Jan 2026.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20254 payments
- PFIZER INC.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Breaking Access Barriers to Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies—an ASTCT-NMDP ACCESS Initiative
Biology of Blood and Marrow Transplantation
2026 - Beyond the usual suspects: pelvic myeloid sarcoma imitating a gynecologic malignancy
International Journal of Gynecological Cancer
2026 - Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy
Biology of Blood and Marrow Transplantation
2025 - Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT
Biology of Blood and Marrow Transplantation
2025 - Statin therapy with CD19-directed CAR-T therapy improves outcomes in relapsed or refractory large B-cell lymphoma
Blood Immunology & Cellular Therapy
2025
Similar KOLs
Other experts from the same institution or the same specialty.
William Zoghbi, MD
Houston Methodist
Eleftherios Mylonakis, MD
Houston Methodist
Dipan Shah, MD
Houston Methodist
Adi Lador, MD
Houston Methodist
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”